Overall rank by patents
#29,385
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView Foreign Corporation
Micromedmark Biotech Co., Ltd.
USPTO PatentsView assignee record - 9 granted patents across 6 technology areas, active 2016–2020. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA).
9
Total patents granted
6
CPC technology areas
11.9
Avg claims per patent
-87%
5-year filing velocity
The verdict
Micromedmark holds 9 US patents across 6 technology areas, rank #29,385 of 50,000 tracked assignees.
- #29,385
- of 50,000 US assignees by volume
- Top 87%
- by Innovation Score (23.8/100)
- 11.9
- avg claims per patent
- -87%
- filing velocity, last 5 yrs
Portfolio overview
Micromedmark Biotech Co., Ltd. has been granted 9 US utility patents between 2016 and 2020, placing Micromedmark Biotech Co., Ltd. at rank #29,385 across all assignees tracked by PlainPatent. This portfolio spans 6 distinct Cooperative Patent Classification (CPC) subclasses, averaging 11.9 claims per patent with primary concentration in C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA). As a Foreign Corporation, Micromedmark Biotech Co., Ltd. is one of the more focused assignees in the PatentsView dataset. By volume, Micromedmark sits between Michael TODD Beauty Lp (9 patents, rank #29,381) and Microvi Biotech, Inc. (9 patents, rank #29,389) - the closest US assignees by grant volume. The composite Innovation Score of 23.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 1 grants, compared with 8 in the 2015–2019 window, a -87% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Micromedmark Biotech Co., Ltd.'s 11.9 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 6 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Micromedmark Biotech Co., Ltd. against peers pursuing similar technology classes.
Who files at Micromedmark's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Michael TODD Beau…
MICHAEL TODD BEAUTY LP
9 patents
- Michelson Diagnos…
MICHELSON DIAGNOSTICS LTD.
9 patents
- Michigan Aerospace
MICHIGAN AEROSPACE CORPORATION
9 patents
- MICO Latta
MICO LATTA INC.
9 patents
- Micronova Manufac…
MICRONOVA MANUFACTURING, INC.
9 patents
- Microsilicon
MICROSILICON, INC.
9 patents
- Microspace
MICROSPACE CORPORATION
9 patents
- Microvi Biotech
MICROVI BIOTECH, INC.
9 patents
- Micromedmark Biot… ◀
MICROMEDMARK BIOTECH CO., LTD.
9 patents
What this shows Micromedmark holds 9 patents at rank #29,385, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Micromedmark
By rank, the assignees closest to #29,385 in granted patent volume.
- Michael TODD Beauty Lp #29,381 · 9 patents
- Michelson Diagnostics Ltd. #29,382 · 9 patents
- Michigan Aerospace Corporation #29,383 · 9 patents
- MICO Latta Inc. #29,384 · 9 patents
- Micronova Manufacturing, Inc. #29,386 · 9 patents
- Microsilicon, Inc. #29,387 · 9 patents
- Microspace Corporation #29,388 · 9 patents
- Microvi Biotech, Inc. #29,389 · 9 patents
Leaders in C12N (Microorganisms OR Enzymes)
Other assignees with the most granted patents in Micromedmark's primary technology class.
- Monsanto Technology Llc 1,335 in class
- The Regents Of The University Of California 1,161 in class
- Novozymes A/s 656 in class
- Immatics Biotechnologies Gmbh 647 in class
- Pioneer Hi-bred International, Inc. 623 in class
- President And Fellows Of Harvard College 594 in class
- Massachusetts Institute Of Technology 541 in class
- The Trustees Of The University Of Pennsylvania 537 in class
Micromedmark's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
24 Top 87% higher than 13% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 4 | 44.4% |
| 2017 | 2 | 22.2% |
| 2019 | 2 | 22.2% |
| 2020 | 1 | 11.1% |
Which technologies does Micromedmark Biotech Co., Ltd. patent most?
Top 6 of 6 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Focused
Claim Depth Simple
Velocity Declining
Frequently Asked Questions
How many patents does Micromedmark Biotech Co., Ltd. hold?
Micromedmark Biotech Co., Ltd. holds 9 US granted patents filed between 2016 and 2020, spanning 6 technology areas.
What is Micromedmark Biotech Co., Ltd.'s Innovation Score?
Micromedmark Biotech Co., Ltd. has an Innovation Score of 23.8 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Micromedmark Biotech Co., Ltd. focus on?
Micromedmark Biotech Co., Ltd.'s top technology area is C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA) with 6 patents. The company has filed patents in 6 CPC subclasses total.
Is Micromedmark Biotech Co., Ltd.'s patent filing rate increasing or decreasing?
Micromedmark Biotech Co., Ltd.'s recent filing velocity is -87% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for Micromedmark Biotech Co., Ltd.'s patents?
Micromedmark Biotech Co., Ltd.'s patents average 11.9 claims each. This is relatively simple claim structure, typical for focused inventions.
How is the Micromedmark Biotech Co., Ltd. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
Micromedmark's 9 grants land it in the top 87% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - Micromedmark ranks #29,385 of 50,000. Top 50 holders
- Most of this portfolio concentrates in C12N - see who else leads that technology area. C12N leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.